ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

PreOmics Introduces New ENRICH-iST Kits and Novel Workflow for Unbiased, Affordable Plasma and Serum Proteomics by LC-MS

  • ENRICH-iST enables unbiased enrichment of lower abundant plasma and serum proteins by 50% to more than 100% in human and rodent plasma proteomics in a cost-effective, fast 5-hour workflow
  • ENRICH-iST utilizes non-functionalized paramagnetic microbeads supporting automated platforms
  • ENRICH-iST enables protein enrichment and tryptic digestion on only 20 microL of starting material

At ASMS 2023, PreOmics GmbH announces the launch of its new ENRICH-iST™ kits, which enable biologically unbiased enrichment of lower abundant plasma and serum proteins onto non-functionalized paramagnetic particles, enhancing typical depths of plasma proteomics analysis by 50% to more than 100%, compared to neat plasma or serum proteomics without depletion or enrichment. The novel ENRICH-iST workflow enables fast and robust processing of up to 96 plasma samples in parallel for reproducible large-cohort translational and clinical research and validation. The affordable ENRICH-iST routine enrichment workflow nicely complements existing ultra-deep plasma proteomics discovery research workflows that either use automated bead depletion or nanoparticle array enrichment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230605005320/en/

ENRICH-iST Kit (displayed in environmentally friendly packaging) is available as an 8x version or as a 96x version for high-throughput plasma proteomics. For both human plasma and serum samples, a significant increase in peptide and protein identification was observed, comparing neat plasma and serum with enriched samples. (Graphic: Business Wire)

ENRICH-iST Kit (displayed in environmentally friendly packaging) is available as an 8x version or as a 96x version for high-throughput plasma proteomics. For both human plasma and serum samples, a significant increase in peptide and protein identification was observed, comparing neat plasma and serum with enriched samples. (Graphic: Business Wire)

The ENRICH-iST technology offers a simple, fast (<5h total) and cost-effective solution for proteomic sample processing of plasma or serum from various species, including human, rodents, NHPs, dogs and pigs. Requiring only 20 microL of starting material, it consistently delivers reproducible, enhanced results for LC-MS analysis, e.g., by DIA-PASEF timsTOF 4D Proteomics mass spectrometry. Utilizing non-functionalized paramagnetic microbeads, the technology enables biologically unbiased enrichment of lower abundant proteins, and supports liquid handling automation platforms, such as Tecan FLUENT systems.

Dr. Andreas-David Brunner, Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, states: “We routinely work with biofluid cohorts collected from preclinical species. The novel ENRICH technology from PreOmics allowed us to achieve reliable and in-depth proteomic data without laborious method development. The new kit worked out of the box; the workflow is intuitive and can be completely automated. This solution allows us to standardize our processes completely, and significantly improves our throughput.”

In a benchmark study, plasma and serum samples from human, mouse and rat specimens (from suppliers Sigma Aldrich, BioIVT and Diaserve Laboratories GmbH) were processed using the novel ENRICH-iST workflow in comparison to antibody-based depletion, as well as to unprocessed neat samples. Peptides were analyzed on a timsTOF HT mass spectrometer (Bruker Daltonics) in DIA-PASEF mode using a 30-minute nanoLC gradient. The ENRICH-iST workflow was shown to increase the proteomic depth of peptides and proteins 1.5x – 2.2x -fold in comparison to neat samples. Typical Coefficients of Variation (CV) within replicates were below 12%, emphasizing high repeatability of the ENRICH-iST workflow. Matching the identified proteins with the plasma proteome database revealed a superior coverage for the ENRICH-iST workflow over neat and depleted samples with identified proteins covering a larger dynamic range. ENRICH-iST showed higher precision over the measured abundance range in comparison to the depletion workflow.

Dr. Catherine Nury, Manager Proteomics, Philip Morris International, Switzerland, comments:We tested several options for biomarker discovery on plasma samples, but many were long and tedious. With the novel ENRICH technology, we have a fast, efficient, and reliable enrichment workflow to get deeper into the proteome from human plasma and serum. We use the ENRICH-iST 96x kits and are delighted by the reproducibility and ease of the kit. We really enjoyed working with the PreOmics team, who are always there to support us. We would strongly recommend the kit to other plasma and serum proteomics users.”

Automation is key for high-throughput plasma proteomics and Luca Valeggia, Senior Vice President - Lab Automation, at Tecan, adds: “We are delighted to continue our collaboration with PreOmics. By automating their new ERICH-iST kit on our Fluent workstation, we’re enabling robust and reproducible high-throughput sample preparation for large cohort studies, helping to further accelerate progress in this rapidly advancing field.”

Have a look yourself: PreOmics representatives will be at ASMS booth #827 to showcase the ENRICH-iST application note. Additional information can be accessed at www.preomics.com/products/enrich-ist.

About PreOmics GmbH

PreOmics empowers our clients in life sciences to establish biological knowledge through efficient, reliable solutions and workflows that set the standard for protein analysis. Our team spirit, energy, and commitment empower us to be both creative and quality focused – a trusted partner with deeply rooted scientific experience. We envisage a future with revolutionary proteomic discovery processes open for everyone. Tools that reveal hidden causes of diseases, ensure sustainable nutrition, and provide diagnoses that enhance lives and society.

Website: www.preomics.com

Address: Am Klopferspitz 19 | 82152 Planegg/Martinsried | Germany

Contacts

Dr. Garwin Pichler, Founder & Managing Director PreOmics GmbH

Email: info@preomics.com

 

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.